Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B - Comparative Cohort Study
Journal Title: Journal of Medical Science And clinical Research - Year 2016, Vol 4, Issue 11
Abstract
Background: Hepatitis B virus (HBV) infection is a global problem and >350 million HBV carriers in the world. HBV infection causes chronic hepatitis and can lead to liver cirrhosis and hepatocellular carcinoma (HCC). Aim: To evaluate safety and efficacy of Tenofovir and Entecavir medications in liver disease course in HBVdecompensated cirrhosis patients Patients & Methods: The study was carried out in hepatology Out-Patient Clinic, Amiri hospital, Kuwait. Forty six HBV decompensated cirrhosis patients were classified into 2 groups; Tenofovir group (n=23) and Entecavir group (n=23). All patients underwent clinical examination, laboratory data (liver profile, HBV DNA, eGFR, Phosphate) and Assessment of Child-Pugh (CP) score, Model for end stage liver disease (M ELD) score before and after treatment. Results: Baseline HBV DNA and liver enzymes of both groups showed no significant difference before treatment. 21 (91.3%) of patients of in each group had undetectable HBV DNA at 12 months. CP and MELD scores among the 2 groups showed improvement in both scores after treatment with similar changes in both scores between the 2 medications at any time. Comparison of eGFR among the 2groups showed no changes at any time in eGFR at each group and in between the 2 groups. Conclusion: Both antivirals (Tenofovir and Entecavir) were well tolerated; none of the patients discontinued therapy, while eGFRs were not different between Tenofovir and Entecavir groups during the follow up period, the patients had excellent virological response without viral breakthrough and with improvement in severity of liver disease.
Authors and Affiliations
Dr. Mahmoud A El Tahawy
Keywords
Related Articles
- EP ID EP214819
- DOI -
- Views 77
- Downloads 0
A Study of Chronic Obstructive Pulmonary Diseases in Post Tuberculosis Patients Reporting in a Tertiary Care Hospital in Eastern India
Background: Chronic Obstructive Pulmonary Diseases (COPD) is a common preventable and treatable disease characterized by persistent airflow limitation. TB is a serious public health problem causing immense morbidity, mor...
Red Blood Cells Morphological Changes as a Prognostic Tool for Organophosphorus Toxicity Patients
Aims & Objectives- Identify and exclude the misinterpretation of peripheral blood smears examination. Identify organophosphorus induced RBC & WBC morphological changes used as a prognostic tool. Identify the organophosph...
Study of Depression, Anxiety and Stress among Tuberculosis patients and its relation with their Life Satisfaction
Given the ease of access to vaccines, drugs and medical treatments for Tuberculosis (TB), the disease continues to be a global health concern. Along with the high prevalence of TB, there is growing awareness of psychiatr...
Assessment of Risk Factors Associated with Coronary Artery Diseases in a Study Population- A Clinical Study
Background: Coronary artery disease (CAD) is one of the most common causes of mortality and morbidity in general population in both developed and developing countries. It is a leading cause of death in India. The present...
Parenteral Organophosphate Poisoning Presenting With Seizure
Organophosphate (OP) poisoning is common in India. Only few case reports of parenteral OP poisoning have been described. We report a case of self-injected methyl parathion poisoning, presenting after four days with seizu...